Cambiar Investors LLC Sells 12,763 Shares of Amdocs Limited (NASDAQ:DOX)

Cambiar Investors LLC lessened its holdings in Amdocs Limited (NASDAQ:DOXFree Report) by 10.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 114,642 shares of the technology company’s stock after selling 12,763 shares during the period. Cambiar Investors LLC’s holdings in Amdocs were worth $9,761,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Nordea Investment Management AB increased its position in Amdocs by 8.3% in the fourth quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company’s stock worth $141,112,000 after purchasing an additional 127,426 shares during the last quarter. Mirabella Financial Services LLP boosted its stake in Amdocs by 204.2% during the third quarter. Mirabella Financial Services LLP now owns 14,302 shares of the technology company’s stock worth $1,250,000 after buying an additional 9,600 shares during the period. Victory Capital Management Inc. boosted its stake in Amdocs by 1.9% during the third quarter. Victory Capital Management Inc. now owns 478,137 shares of the technology company’s stock worth $41,827,000 after buying an additional 9,098 shares during the period. Pacer Advisors Inc. boosted its stake in Amdocs by 7.4% during the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company’s stock worth $154,587,000 after buying an additional 125,654 shares during the period. Finally, Crossmark Global Holdings Inc. boosted its stake in Amdocs by 34.7% during the third quarter. Crossmark Global Holdings Inc. now owns 145,556 shares of the technology company’s stock worth $12,733,000 after buying an additional 37,516 shares during the period. Institutional investors own 92.02% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on DOX shares. StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, February 5th. Oppenheimer lifted their price objective on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Finally, Barclays dropped their price objective on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $101.20.

Read Our Latest Analysis on DOX

Amdocs Stock Down 0.2 %

Shares of DOX opened at $85.80 on Tuesday. The firm has a market capitalization of $9.69 billion, a P/E ratio of 19.91, a P/E/G ratio of 1.41 and a beta of 0.71. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The firm has a fifty day moving average price of $85.94 and a 200-day moving average price of $86.47.

Amdocs (NASDAQ:DOXGet Free Report) last released its quarterly earnings data on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing analysts’ consensus estimates of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Equities research analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Sunday, April 20th. Shareholders of record on Monday, March 31st will be issued a $0.527 dividend. The ex-dividend date of this dividend is Monday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.46%. Amdocs’s payout ratio is currently 44.55%.

About Amdocs

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.